|
1
|
Veligeti R, Anireddy JS, Madhu RB, Ramakrishna D. One pot, three component synthesis of fluoro and trifluoromethyl substituted unsymmetrical dihydropyrazine fused acridine-3-carboxamide using renewable 2-MeTHF solvent and their DFT studies. J Fluor Chem 2022. [DOI: 10.1016/j.jfluchem.2022.110019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
|
2
|
Synthesis, characterization, and biological evaluations of substituted phenethylamine-based urea as anticancer and antioxidant agents. MONATSHEFTE FUR CHEMIE 2021. [DOI: 10.1007/s00706-021-02830-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
|
3
|
Abstract
The urea functionality is inherent to numerous bioactive compounds, including a variety of clinically approved therapies. Urea containing compounds are increasingly used in medicinal chemistry and drug design in order to establish key drug-target interactions and fine-tune crucial drug-like properties. In this perspective, we highlight physicochemical and conformational properties of urea derivatives. We provide outlines of traditional reagents and chemical procedures for the preparation of ureas. Also, we discuss newly developed methodologies mainly aimed at overcoming safety issues associated with traditional synthesis. Finally, we provide a broad overview of urea-based medicinally relevant compounds, ranging from approved drugs to recent medicinal chemistry developments.
Collapse
Affiliation(s)
- Arun K Ghosh
- Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States
| | - Margherita Brindisi
- Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana 47907, United States.,Department of Excellence of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
| |
Collapse
|
|
4
|
Wu YC, Ren XY, Rao GW. Research Progress of Diphenyl Urea Derivatives as Anticancer Agents and Synthetic Methodologies. MINI-REV ORG CHEM 2019. [DOI: 10.2174/1570193x15666181029130418] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The malignant neoplasm, which is recognized as cancer, is a serious threat to human
health and frequently-occurring disease. Diphenylurea, an important link structure in the design of
active substance for treating cancer due to its near-perfect binding with certain acceptors, has demonstrated
many activities against several human cancer cell lines. Various novel compounds with diphenyl
urea as anticancer agents were constructed with the successful development of sorafenib.
Diphenylurea is utilized to treat cancer by inhibiting cell signaling transduction, such as RAS-RAFMEK-
ERK signaling pathway and PI3K-Akt-mTOR pathway. In addition, this structure inhibits tumor
cell growth by inhibiting receptor tyrosine kinases multiply, such as Vascular Endothelial
Growth Factor Receptors (VEGFRs), Platelet-Derived Growth Factor Receptors (PDGFRs), Epidermal
Growth Factor Receptors (EGFRs). It regulates the pH value in cells by inhibiting CAIX/XII and
to achieve cancer therapeutic effect. Besides, the diphenyl urea structure is applied to the synthesis of
reagents like Aurora kinases inhibitors and HDAC inhibitors that affect cell division and differentiation
to treat cancer. To reach the goal of treating tumor, this structure is also used as a DNA-directed
alkylating agent by affecting the expression of genes. An application of the most representative diphenyl
urea derivatives as antitumor agents is summarized in this review, focusing on their mechanisms
bound to the targets. Meanwhile, the progress of researches on methods of synthesizing diphenyl
urea derivatives is provided.
Collapse
Affiliation(s)
- Yi-Cong Wu
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| | - Xin-Yue Ren
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| | - Guo-Wu Rao
- College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China
| |
Collapse
|
|
5
|
Lotfy G, El Ashry ESH, Said MM, El Tamany ES, Abdel Aziz YM, Al-Dhfyan A, Al-Majid AM, Barakat A. Regio- and stereoselective synthesis of new spirooxindoles via 1,3-dipolar cycloaddition reaction: Anticancer and molecular docking studies. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY 2018; 180:98-108. [DOI: 10.1016/j.jphotobiol.2018.01.026] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/11/2017] [Revised: 12/30/2017] [Accepted: 01/24/2018] [Indexed: 11/28/2022]
|
|
6
|
Shan Y, Wang C, Zhang L, Wang J, Wang M, Dong Y. Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors. Bioorg Med Chem 2016; 24:750-8. [DOI: 10.1016/j.bmc.2015.12.038] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2015] [Revised: 12/19/2015] [Accepted: 12/23/2015] [Indexed: 11/27/2022]
|
|
7
|
Lu C, Tang K, Li Y, Li P, Lin Z, Yin D, Chen X, Huang H. Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents. Eur J Med Chem 2014; 77:351-60. [PMID: 24675135 DOI: 10.1016/j.ejmech.2014.03.020] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/25/2013] [Revised: 02/04/2014] [Accepted: 03/08/2014] [Indexed: 01/07/2023]
Abstract
A novel series of diaryl ureas containing different linker groups were designed and synthesized. Their in vitro antitumor activity against MX-1, A375, HepG2, Ketr3 and HT-29 was evaluated using the standard MTT assay. Compounds having a rigid linker group such as vinyl, ethynyl and phenyl showed significant inhibitory activity against a variety of cancer cell lines. Specifically, compound 23 with a phenyl linker group demonstrated broad-spectrum antitumor activity with IC50 values of 5.17-6.46 μM against five tested tumor cell lines. Compound 23 is more potent than reference drug sorafenib (8.27-15.2 μM), representing a promising lead for further optimization.
Collapse
Affiliation(s)
- Chenshu Lu
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
| | - Ke Tang
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
| | - Yan Li
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
| | - Peng Li
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
| | - Ziyun Lin
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
| | - Dali Yin
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
| | - Xiaoguang Chen
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China.
| | - Haihong Huang
- Beijing Key Laboratory of Active Substances Discovery and Druggability Evaluation, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China.
| |
Collapse
|
|
8
|
Zhou S, Yao T, Yi J, Li D, Xiong J. A Simple and Efficient Synthesis of Diaryl Ureas with Reduction of the Intermediate Isocyanate by Triethylamine. JOURNAL OF CHEMICAL RESEARCH 2013. [DOI: 10.3184/174751913x13663925002708] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Thirty symmetrical diaryl urea derivatives were synthesised in moderate to excellent yields from arylamine and triphosgene with triethylamine as a reducing agent for the intermediate, isocyanate. It was significant that part of the products could be collected in almost quantitative yield without column chromatography. The procedure under mild reaction conditions was tolerant of a wide range of functional groups. The structures of the compounds were determined by NMR, MS and X-ray crystallographic analyses.
Collapse
Affiliation(s)
- Shuguang Zhou
- College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, 325035, P. R. China
| | - Ting Yao
- College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, 325035, P. R. China
| | - Jicheng Yi
- College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, 325035, P. R. China
| | - Dashuai Li
- College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, 325035, P. R. China
| | - Jing Xiong
- College of Chemistry and Materials Engineering, Wenzhou University, Wenzhou, 325035, P. R. China
| |
Collapse
|